Allianz Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24M | Buy |
8,100
+2,900
| +56% | +$445K | ﹤0.01% | 1680 |
|
|
2025
Q4 | $717K | Buy |
5,200
+900
| +21% | +$118K | ﹤0.01% | 1784 |
|
|
2025
Q3 | $551K | Sell |
4,300
-2,000
| -32% | -$244K | ﹤0.01% | 1824 |
|
|
2025
Q2 | $762K | Sell |
6,300
-400
| -6% | -$45.1K | ﹤0.01% | 1731 |
|
|
2025
Q1 | $747K | Buy |
6,700
+1,100
| +20% | +$117K | ﹤0.01% | 1755 |
|
|
2024
Q4 | $545K | Sell |
5,600
-2,200
| -28% | -$235K | ﹤0.01% | 1839 |
|
|
2024
Q3 | $897K | Hold |
7,800
| – | – | ﹤0.01% | 1661 |
|
|
2024
Q2 | $830K | Buy |
+7,800
| New | +$783K | ﹤0.01% | 1653 |
|
|
2022
Q3 | – | Sell |
-46,316
| Closed | -$3.92M | – | 2046 |
|
|
2022
Q2 | $3.92M | Sell |
46,316
-73,785
| -61% | -$6.47M | ﹤0.01% | 1180 |
|
|
2022
Q1 | $10.5M | Sell |
120,101
-950
| -0.8% | -$82.3K | 0.01% | 972 |
|
|
2021
Q4 | $10.6M | Sell |
121,051
-915
| -0.8% | -$76K | 0.01% | 978 |
|
|
2021
Q3 | $9.97M | Buy |
121,966
+10,610
| +10% | +$955K | 0.01% | 1017 |
|
|
2021
Q2 | $10.2M | Sell |
111,356
-2,615
| -2% | -$233K | 0.01% | 855 |
|
|
2021
Q1 | $9.74M | Sell |
113,971
-9,495
| -8% | -$852K | 0.01% | 839 |
|
|
2020
Q4 | $11.7M | Sell |
123,466
-30,918
| -20% | -$2.7M | 0.01% | 790 |
|
|
2020
Q3 | $13.4M | Buy |
154,384
+29
| +0% | +$2.51K | 0.02% | 692 |
|
|
2020
Q2 | $13.5M | Sell |
154,355
-13,830
| -8% | -$1.19M | 0.02% | 775 |
|
|
2020
Q1 | $13.9M | Buy |
168,185
+8,464
| +5% | +$755K | 0.02% | 706 |
|
|
2019
Q4 | $15.1M | Buy |
159,721
+10,865
| +7% | +$975K | 0.01% | 922 |
|
|
2019
Q3 | $12.9M | Sell |
148,856
-15,640
| -10% | -$1.4M | 0.01% | 982 |
|
|
2019
Q2 | $15M | Sell |
164,496
-13,853
| -8% | -$1.17M | 0.01% | 951 |
|
|
2019
Q1 | $15.4M | Buy |
178,349
+13,331
| +8% | +$1.07M | 0.02% | 885 |
|
|
2018
Q4 | $12.7M | Sell |
165,018
-67,909
| -29% | -$5.29M | 0.01% | 989 |
|
|
2018
Q3 | $18M | Buy |
232,927
+184,960
| +386% | +$13.7M | 0.02% | 956 |
|
|
2018
Q2 | $3.25M | Buy |
47,967
+376
| +0.8% | +$25.9K | ﹤0.01% | 1729 |
|
|
2018
Q1 | $3.45M | Buy |
47,591
+383
| +0.8% | +$29.2K | ﹤0.01% | 1694 |
|
|
2017
Q4 | $3.55M | Buy |
47,208
+6,361
| +16% | +$480K | ﹤0.01% | 1779 |
|
|
2017
Q3 | $3.14M | Hold |
40,847
| – | – | ﹤0.01% | 1845 |
|
|
2017
Q2 | $3.06M | Sell |
40,847
-461
| -1% | -$32.7K | ﹤0.01% | 1828 |
|
|
2017
Q1 | $2.75M | Sell |
41,308
-2,850
| -6% | -$190K | ﹤0.01% | 1874 |
|
|
2016
Q4 | $2.88M | Buy |
44,158
+374
| +0.9% | +$24.3K | ﹤0.01% | 1833 |
|
|
2016
Q3 | $3.1M | Sell |
43,784
-6,685
| -13% | -$487K | ﹤0.01% | 1814 |
|
|
2016
Q2 | $3.73M | Buy |
50,469
+2,868
| +6% | +$198K | ﹤0.01% | 1638 |
|
|
2016
Q1 | $3.09M | Buy |
47,601
+10,360
| +28% | +$705K | ﹤0.01% | 1623 |
|
|
2015
Q4 | $2.87M | Hold |
37,241
| – | – | ﹤0.01% | 1559 |
|
|
2015
Q3 | $3.07M | Buy |
37,241
+8,125
| +28% | +$723K | ﹤0.01% | 1460 |
|
|
2015
Q2 | $2.57M | Sell |
29,116
-57,256
| -66% | -$5.25M | ﹤0.01% | 1610 |
|
|
2015
Q1 | $7.63M | Sell |
86,372
-28,910
| -25% | -$2.56M | 0.01% | 1060 |
|
|
2014
Q4 | $9.57M | Buy |
115,282
+2,260
| +2% | +$187K | 0.01% | 970 |
|
|
2014
Q3 | $8.93M | Buy |
113,022
+83,522
| +283% | +$6.76M | 0.01% | 869 |
|
|
2014
Q2 | $2.39M | Buy |
29,500
+111
| +0.4% | +$8.73K | ﹤0.01% | 1138 |
|
|
2014
Q1 | $1.81M | Buy |
+29,389
| New | +$2.14M | ﹤0.01% | 1239 |
|
Other funds holding NVS
Allianz Asset Management's NVS Position: Q1 2026 in Review
Allianz Asset Management increased its Novartis (NVS) stake by 56% in Q1 2026, buying an estimated $445K and bringing the position to 8,100 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.
Allianz Asset Management first reported a position in NVS in Q1 2014 and has held it in 42 quarters since. The position peaked at $18M in Q3 2018. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Allianz Asset Management held 8,100 shares of Novartis worth $1.24M as of Q1 2026.
- Allianz Asset Management bought 2,900 Novartis shares in Q1 2026, an estimated $445K.
- Novartis made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1680 holding.
- Allianz Asset Management first reported a position in Novartis in Q1 2014 and has held it in 42 quarters since.
- Allianz Asset Management's Novartis position peaked at $18M in Q3 2018.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.